Shaw Centre

Broker's Calls

Raffles Medical Group to retain its vigour in the face of near-term headwinds

SINGAPORE (March 29): Maybank Kim Eng Research is reiterating its “buy” call on Raffles Medical Group at an unchanged price target of $1.70, after having hosted the private healthcare provider at its recent Invest ASEAN Singapore Conference.

Broker's Calls

Raffles Medical’s plans ‘steadily taking shape’ but cost pressures may weigh on profitability

SINGAPORE (Sept 29): Daiwa Capital Markets is keeping its “hold” rating on Raffles Medical Group RMG) at an unchanged target price of $1.57 as the group continues its press ahead with its expansion plans.